Ads
related to: acute myeloid leukemia- Info On Myelofibrosis
Learn About Myelofibrosis By
Viewing The Patient Site For More.
- Know The Side Effects
Explore The Risks And Side Effects
Of MF Treatment Option Today.
- View Myelofibrosis Info
Visit The Official Patient Site To
Learn About A Treatment Option.
- Discover Ways To Save
Review Resources & Savings Options
For Treatment On The Patient Site.
- Info On Myelofibrosis
Search results
Benzene Exposure Linked to Acute Myeloid Leukemia, Aplastic Anemia, and Lymphomas | JD Supra
JD Supra· 13 hours agoIf you have been diagnosed with acute myeloid leukemia but cannot figure out why, benzene may be responsible. Benzene, a chemical used ...
Patients Over 80 Still Benefit From Treatment for AML Blood Cancer
Alaska Superstation· 3 days agoSeniors over 80 with acute myeloid leukemia can safely and effectively take the standard targeted...
Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in TP53 Positive Patients...
NBC 17 Raleigh· 3 days agoThe Phase 3 SIERRA trial enrolled 153 patients ages 55 and above with active relapsed or refractory acute myeloid leukemia (r/r AML) ...
Ryvu Therapeutics First Quarter 2024 Financial Results and Corporate Update
WJTV Jackson· 3 days agoAs of May 9, 2024, Ryvu's cash position was $59.0M, inclusive of the first tranche of €8M in venture debt from the EIB, obtained in March. This cash position, and other secured funding sources ...
Actinium Announces Multiple Abstracts Highlighting its Antibody Radiation Conjugates Iomab-B and...
WJTV Jackson· 4 days agoIomab-B and Actimab-A are the only targeted radiotherapies in development for patients with relapsed/refractory acute myeloid leukemia
Earnings call: Aptose Biosciences targets AML treatment with tuspetinib By Investing.com
Investing.com· 2 days agoAptose Biosciences (NASDAQ:APTO) has focused its efforts on developing tuspetinib as part of a novel...
Ryvu Therapeutics to present clinical and preclinical data on RVU120 at the 2024 European Hematology...
FOX 23 News Albany· 3 days agoUpdated data from the Phase I trial of RVU120 in patients with relapsed/refractory acute myeloid ...
After 25 years selling Harleys, Gail Worth will soon close KC business. She has plans
Kansas City Star via Yahoo Finance· 3 days ago“He was my best friend in my whole life,” Worth said of Adams, who died in April after battling ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoMoleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress PR Newswire HOUSTON, May 16, 2024 HOUSTON, May 16, 2024 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or
Local Leukemia & Lymphoma Society holds annual fundraiser for blood cancer research
Local 12 Cincinnati· 1 day agoThe local chapter of the Leukemia and Lymphoma Society held its annual fundraiser to raise money for...
Ad
related to: acute myeloid leukemia
